4.6 Review

HypoxamiRs: regulators of cardiac hypoxia and energy metabolism

Journal

TRENDS IN ENDOCRINOLOGY AND METABOLISM
Volume 26, Issue 9, Pages 502-508

Publisher

ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tem.2015.06.008

Keywords

hypoxia; cardiovascular disease; microRNAs; hypoxamiRs; therapeutics

Funding

  1. Netherlands CardioVascular Research Initiative: the Dutch Heart Foundation
  2. Dutch Federation of University Medical Centers
  3. Netherlands Organization for Health Research and Development (ZonMW)
  4. Royal Netherlands Academy of Sciences
  5. European Research Council (ERC) [311549]
  6. European Research Council (ERC) [311549] Funding Source: European Research Council (ERC)

Ask authors/readers for more resources

Hypoxia and its intricate regulation are at the epicenter of cardiovascular research. Mediated by hypoxia-inducible factors as well as by several microRNAs, recently termed 'hypoxamiRs', hypoxia affects several cardiac pathophysiological processes. Hypoxia is the driving force behind the regulation of the characteristic metabolic switch from predominant fatty acid oxidation in the healthy heart to glucose utilization in the failing myocardium, but also instigates reactivation of the fetal gene program, induces the cardiac hypertrophy response, alters extracellular matrix composition, influences mitochondrial biogenesis, and impacts upon myocardial contractility. HypoxamiR regulation adds a new level of complexity to this multitude of hypoxia-mediated effects, rendering the understanding of the hypoxic response a fundamental piece in solving the cardiovascular disease puzzle.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available